<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00812604</url>
  </required_header>
  <id_info>
    <org_study_id>HKCTR-466</org_study_id>
    <nct_id>NCT00812604</nct_id>
  </id_info>
  <brief_title>Analgesic Ointment on Temporomandibular Joint and Masticatory Muscle Pain</brief_title>
  <official_title>Effect of an Analgesic Ointment on the Relief of Temporomandibular Joint and Masticatory Muscle Pain: a Randomized, Double Blinded, Placebo-controlled Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Hong Kong</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the effectiveness of using topical cream of Ping On
      Ointment and using Vaseline cream in the treatment of temporomandibular joint (TMJ) and
      masticatory muscle pain, in order to establish the true efficacy of Ping On Ointment. Both
      Ping On Ointment and Vaseline are considered intervention.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aims: To compare the effectiveness of using topical cream of Ping On Ointment and using
      Vaseline cream in the treatment of temporomandibular joint (TMJ) and masticatory muscle pain,
      in order to establish the true efficacy of Ping On Ointment. Methods: In this randomized,
      double-blinded, placebo-controlled trial, 55 subjects with TMJ and/or masticatory pain (Group
      1 patients according to the Research Diagnostic Criteria for Temporomandibular Disorder
      (RDC/TMD) received Ping On Ointment for 4 weeks; or placebo for 4 weeks. Subjects were
      evaluated with standard measures of efficacy: pain intensity measured by visual analogue
      scale and maximal comfortable mandibular opening, at baseline and again after 4 weeks of
      treatment.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2007</start_date>
  <completion_date type="Actual">September 2008</completion_date>
  <primary_completion_date type="Actual">June 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The Efficacy in the Treatment of TMJ and Muscle Pain</measure>
    <time_frame>4 weeks</time_frame>
    <description>The efficacy in the treatment of TMJ and muscle pain is measured by a visual analogue scale (VAS).
The VAS consists of a 100 mm line, anchored with the extremes of pain intensity represented as &quot;no pain&quot; ( 0 mm) and &quot; worst pain possible&quot; ( 100 mm).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The Mandibular Function.</measure>
    <time_frame>4 weeks</time_frame>
    <description>The mandibular function, the maximal comfortable mandibular opening measured in millimeters at the subjects's maximum incisor to incisor mouth opening using a ruler.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">55</enrollment>
  <condition>Temporomandibular Disorders</condition>
  <arm_group>
    <arm_group_label>Ping On Ointment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ping On Ointment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vaseline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Vaseline with minor trace of Ping On ointment to give medicinal smell</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ping On Ointment</intervention_name>
    <description>Ping On Ointment</description>
    <arm_group_label>Ping On Ointment</arm_group_label>
    <other_name>TCM topical analgesic</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vaseline</intervention_name>
    <description>Placebo</description>
    <arm_group_label>Vaseline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Self report of facial ache or pain in the muscles of mastication, the TMJ, or the
             region in front of ear or inside the ear

          2. Positive clinical diagnosis of TMDs. The TMD diagnosis is classified using axis I of
             the research diagnostic criteria ( RDC) for TMDs. The RDC diagnosis consists of joint
             pain at rest ( spontaneous pain) and evoked pain (hyperalgesia) on palpation of the
             TMJ, TMJ reduction consists of reciprocal clicking or joint noise with mandibular
             movement examination.

          3. For joint pain complaint, subjects will be required to have a self-report of at least
             1 month of daily or nearly-daily pain.

          4. Subjects with myogenic pain will be included if they meet inclusion and exclusion
             criteria since patients with TMDs are known to exhibit muscle pain secondary to their
             joint dysfunction.

        Exclusion Criteria:

          1. Subjects with infectious arthritis, crystal induced arthropathies, musculoskeletal
             disorders, subjects with a primary diagnosis of myofascial pain based on the RDC;

          2. Subjects with pain attributable to confirmed migraine or head pain condition other
             than tension headache;

          3. Subjects with acute infection or other significant disease of teeth, ears, eyes, nose
             or throats; subjects with untreated depressive disorder or not on stable
             antidepressant medication for more than 6 months;

          4. Subjects with dental diseases that required ongoing treatment, which would confound
             the evaluation of orofacial pain;

          5. Subjects who are not competent in giving consents.

          6. Pregnant or lactating women

          7. Subjects with sensitivity to the ingredient of Ping On Ointment will be excluded.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ricky W. K. Wong, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Orthodontics, Faculty of Dentistry, University of Hong Kong</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculty of Dentistry, The University of Hong Kong</name>
      <address>
        <city>Hong Kong</city>
        <state>Hong Kong</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 19, 2008</study_first_submitted>
  <study_first_submitted_qc>December 19, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 22, 2008</study_first_posted>
  <results_first_submitted>June 26, 2012</results_first_submitted>
  <results_first_submitted_qc>May 21, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 23, 2014</results_first_posted>
  <last_update_submitted>May 21, 2014</last_update_submitted>
  <last_update_submitted_qc>May 21, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 23, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Hong Kong</investigator_affiliation>
    <investigator_full_name>Wong Wing Kit, Ricky</investigator_full_name>
    <investigator_title>Associate Professor, Orthodontics, Faculty of Dentistry</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Temporomandibular Joint Disorders</mesh_term>
    <mesh_term>Temporomandibular Joint Dysfunction Syndrome</mesh_term>
    <mesh_term>Myalgia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Analgesics</mesh_term>
    <mesh_term>Petrolatum</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Ping On Ointment Group</title>
          <description>Ping On Ointment was used</description>
        </group>
        <group group_id="P2">
          <title>Placebo Group</title>
          <description>Vaseline with minor trace of Ping On Ointment was used</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="28"/>
                <participants group_id="P2" count="27"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="22"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Ping On Ointment Group</title>
          <description>Ping On Ointment was used</description>
        </group>
        <group group_id="B2">
          <title>Placebo Group</title>
          <description>Vaseline with minor trace of Ping On Ointment was used</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="28"/>
            <count group_id="B2" value="27"/>
            <count group_id="B3" value="55"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="47.14" spread="9.296"/>
                    <measurement group_id="B2" value="43.96" spread="13.127"/>
                    <measurement group_id="B3" value="45.51" spread="11.401"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Hong Kong</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>The Efficacy in the Treatment of TMJ and Muscle Pain</title>
        <description>The efficacy in the treatment of TMJ and muscle pain is measured by a visual analogue scale (VAS).
The VAS consists of a 100 mm line, anchored with the extremes of pain intensity represented as “no pain&quot; ( 0 mm) and &quot; worst pain possible&quot; ( 100 mm).</description>
        <time_frame>4 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ping On Ointment Group</title>
            <description>Ping On Ointment was used</description>
          </group>
          <group group_id="O2">
            <title>Placebo Group</title>
            <description>Vaseline with minor trace of Ping On Ointment was used</description>
          </group>
        </group_list>
        <measure>
          <title>The Efficacy in the Treatment of TMJ and Muscle Pain</title>
          <description>The efficacy in the treatment of TMJ and muscle pain is measured by a visual analogue scale (VAS).
The VAS consists of a 100 mm line, anchored with the extremes of pain intensity represented as “no pain&quot; ( 0 mm) and &quot; worst pain possible&quot; ( 100 mm).</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.93" spread="18.07"/>
                    <measurement group_id="O2" value="40.81" spread="14.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Mandibular Function.</title>
        <description>The mandibular function, the maximal comfortable mandibular opening measured in millimeters at the subjects's maximum incisor to incisor mouth opening using a ruler.</description>
        <time_frame>4 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ping On Ointment Group</title>
            <description>Ping On Ointment was used</description>
          </group>
          <group group_id="O2">
            <title>Placebo Group</title>
            <description>Vaseline with minor trace of Ping On Ointment was used</description>
          </group>
        </group_list>
        <measure>
          <title>The Mandibular Function.</title>
          <description>The mandibular function, the maximal comfortable mandibular opening measured in millimeters at the subjects's maximum incisor to incisor mouth opening using a ruler.</description>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.435" spread="6.680"/>
                    <measurement group_id="O2" value="0.818" spread="3.404"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Ping On Ointment Group</title>
          <description>Ping On Ointment was used</description>
        </group>
        <group group_id="E2">
          <title>Placebo Group</title>
          <description>Vaseline with minor trace of Ping On Ointment was used</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>In this study, the subjects were screened by clinical examinations and self-reported questionnaires. Ideally, the diagnosis should be made with a combination of radiographs, Magnetic Resonance Imaging or Computer Tomography.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Ricky Wing Kit Wong, Associate professor in orthodontics</name_or_title>
      <organization>University of Hong Kong</organization>
      <phone>852-2859 0554</phone>
      <email>fyoung@hkucc.hku.hk</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

